Or. Admin. R. 415-020-0025 - Admission Policies and Procedures

Current through Register Vol. 61, No. 4, April 1, 2022

(1) Admission Criteria: The Opioid Treatment Program shall have written criteria for accepting or rejecting admission requests. The criteria shall be available to patients, staff, and the community, and require:
(a) Evidence of current physical dependence on narcotics or opiates as determined by the program physician, medical director, or a qualified nurse practitioner, or physicians' assistant;
(b) A one year history, immediately prior to admission, of a continuous physical dependence on narcotics or opiates as documented by medical records, records of arrests for possession of narcotics, or records from drug treatment programs; or
(c) Documentation that medically supervised withdrawal or medically supervised withdrawal with acupuncture and counseling has proven ineffective or that a physician licensed by the Oregon State Board of Medical Examiners has documentation in the patient record that there is a medical need to administer opioid agonist medications;
(d) Documentation that an initial urinalysis test has been completed and screened for opiates, methadone, benzodiazepines, barbiturates, cocaine, amphetamines, and Tetrahydrocannabinol (THC);
(e) That each patient voluntarily chooses opioid treatment and that all relevant facts concerning the use of an opioid agonist drug have been clearly and adequately explained;
(f) Documentation that the patient has provided written informed consent to treatment.
(2) Admission Criteria Exceptions: If clinically appropriate, the program physician may waive the requirement for a one-year history of opioid addiction for patients who:
(a) Have been released from a corrections facility within the previous six months;
(b) Are pregnant and whose pregnancy has been verified by the program physician; or
(c) Have previously been treated and discharged from opioid treatment programs within the last two years.
(3) Refusing Admissions: A patient may be refused opioid treatment even if the patient meets admission standards if, in the professional judgment of the medical director, a particular patient would not benefit from opioid treatment. The reasons for the refusal must be documented in the patient file within seven days following the refusal decision.
(4) Minors: No person under 18 years of age may be admitted to an opioid treatment program unless:
(a) A parent, legal guardian, or responsible adult designated by the State provides written consent for treatment; and
(b) The program can document two unsuccessful attempts at short-term medically supervised withdrawal or drug free treatment within a 12-month period.
(5) Pregnant Patients: Admission and treatment of pregnant patients regardless of age is allowed under the following conditions:
(a) The patient has had a documented narcotic dependency in the past and may be in direct jeopardy of returning to narcotic dependency. For such patients, evidence of current physiological dependence on narcotic drugs is not needed if a program physician certifies the pregnancy and, in his or her reasonable clinical judgment, finds treatment to be medically justified. Evidence of all findings and the criteria used to determine the findings are required to be recorded in the patient's record by the admitting program physician, or by program personnel supervised by the admitting program physician;
(b) The patient undergoes a prenatal exam and health check to verify the pregnancy and identify any health problems;
(c) The patient is given the opportunity for prenatal care either by the program or by referral to appropriate health care providers. If a program cannot provide direct prenatal care for pregnant patients in treatment, the program shall establish a system for informing the patient of the publicly or privately funded prenatal care opportunities available. If there are no publicly funded prenatal referral opportunities and the program cannot provide such services or the patient cannot afford them or refuses them, then the treatment program shall, at a minimum, offer her basic prenatal instruction on maternal, physical, and dietary care as part of its counseling service;
(d) The patient is fully informed concerning risks to herself and her unborn child from the use of methadone and other drugs, including alcohol.
(6) Intake Procedures: The program shall utilize a written intake procedure. The procedure shall require:
(a) Documentation that the medical director has:
(A) Examined and approved all admissions;
(B) Recorded in the patient's record the criteria used to determine the patient's current dependence and history of addiction; and
(C) Determined that the opioid treatment program's services are appropriate to the needs of the patient.
(b) A specific time limit within which the initial patient assessment must be completed on each patient prior to the initial dose of an opioid agonist treatment medication;
(c) Documentation that individuals not admitted to the opioid treatment program were referred to appropriate treatment or other services.
(7) Orientation Information: The program shall give to, and document the receipt of, written program orientation information. The program shall also make the information available to others. The information given shall include:
(a) The program's philosophical approach to treatment;
(b) A description of the program's stages of treatment;
(c) Information on patients rights and responsibilities, including confidentiality, while receiving services;
(d) Information on the rules governing patient behavior and those infractions that may result in discharge or other actions. As a minimum these rules shall state the consequence of alcohol and other drug use, absences from appointments, non-payment of fees, criminal behavior, and failure to participate in the planned treatment program including school, work, or homemaker activities;
(e) Information on the specific hours of service available, methods to accommodate patient needs before and after normal working hours, and emergency services information; and
(f) A schedule of fees and charges.
(8) Patient Record: The following information shall be recorded in each patient's record at the time of admission:
(a) Name, address, and telephone number;
(b) Whom to contact in case of an emergency;
(c) Name of individual completing intake; and
(d) If the patient refuses to provide necessary information, documentation of that fact in the patient file.
(9) Initial Medical Examination Services: Opioid Treatment Programs shall require each patient to undergo a complete, fully documented physical evaluation by a physician, or medical professional under the supervision of a physician before admission to the program. The laboratory tests must be completed within 14 days of admission and must include;
(a) A skin test for tuberculosis, followed by a chest x-ray if the test is positive;
(b) A screening test for syphilis; and
(c) Other laboratory tests as clinically indicated by the patient history and physical examination.

Notes

Or. Admin. R. 415-020-0025
HR 4-1988, f. & cert. ef. 5-10-88; HR 17-1993, f. & cert. ef. 7-23-93, Renumbered from 410-006-0025; ADAP 3-1995, f. 12-1-95, cert. ef. 3-1-96; ADS 1-2003, f. 6-13-03, cert. ef. 7-1-03; ADS 2-2008, f. & cert. ef. 11-13-08; ADS 2-2021, temporary amend filed 09/21/2021, effective 10/01/2021 through 03/29/2022; ADS 3-2021, temporary amend filed 09/29/2021, effective 10/1/2021 through 3/29/2022; ADS 1-2022, amend filed 03/25/2022, effective 3/28/2022

Statutory/Other Authority: ORS 430.256

Statutes/Other Implemented: ORS 430.010(4)(b) & 430.560 - 430.590

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.